E 111: isomer of E 110; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 16868 |
SCHEMBL ID | 342135 |
SCHEMBL ID | 1507664 |
MeSH ID | M0079417 |
Synonym |
---|
food orange 2 |
e 111 |
disodium 6-hydroxy-5-((3-sulfophenyl)azo)-2-naphthalenesulfonate |
unii-35hf83708u |
ci 15980 |
6-hydroxy-5-((3-sulfophenyl)azo)-2-naphthalenesulfonic acid, disodium salt |
einecs 219-073-7 |
disodium 6-hydroxy-5-((3-sulphonatophenyl)azo)naphthalene-2-sulphonate |
2-naphthalenesulfonic acid, 6-hydroxy-5-((3-sulfophenyl)azo)-, disodium salt |
c.i. food orange 2 |
c.i. 15980 |
35hf83708u , |
2347-72-0 |
6-hydroxy-5-((3-sulphophenyl)azo)naphthalene-2-sulphonic acid, sodium salt |
85283-70-1 |
einecs 286-599-1 |
orange ggn |
SCHEMBL342135 |
ci 15980 [inci] |
2-naphthalenesulfonic acid, 6-hydroxy-5-(2-(3-sulfophenyl)diazenyl)-, sodium salt (1:2) |
food orange 2 (e 111) |
disodium 6-hydroxy-5-((3-sulfophenyl)azo)-2- naphthalenesulfonate |
SCHEMBL1507664 |
disodium 6-hydroxy-5-[(3-sulphonatophenyl)azo]naphthalene-2-sulphonate |
6-hydroxy-5-[(3-sulfophenyl)azo]naphthalene-2-sulfonic acid,sodium salt |
J-015123 |
DTXSID90893685 |
Q929052 |
disodium;6-hydroxy-5-[(3-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (62.90) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |